Esperion Therapeutics Inc (ESPR)
1.995
-0.04
(-1.72%)
USD |
NASDAQ |
Nov 04, 16:00
2.01
+0.02
(+0.75%)
After-Hours: 20:00
Esperion Therapeutics Total Liabilities (Quarterly): 696.54M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 696.54M |
| March 31, 2024 | 667.36M |
| December 31, 2023 | 660.79M |
| September 30, 2023 | 631.31M |
| June 30, 2023 | 606.60M |
| March 31, 2023 | 581.48M |
| December 31, 2022 | 571.72M |
| September 30, 2022 | 606.93M |
| June 30, 2022 | 595.68M |
| March 31, 2022 | 591.89M |
| December 31, 2021 | 578.53M |
| September 30, 2021 | 587.96M |
| June 30, 2021 | 584.77M |
| March 31, 2021 | 548.00M |
| December 31, 2020 | 449.39M |
| September 30, 2020 | 242.01M |
| June 30, 2020 | 244.86M |
| March 31, 2020 | 229.89M |
| December 31, 2019 | 194.50M |
| September 30, 2019 | 186.76M |
| June 30, 2019 | 179.48M |
| March 31, 2019 | 61.47M |
| December 31, 2018 | 64.33M |
| September 30, 2018 | 42.28M |
| Date | Value |
|---|---|
| June 30, 2018 | 34.96M |
| March 31, 2018 | 30.05M |
| December 31, 2017 | 33.14M |
| September 30, 2017 | 35.00M |
| June 30, 2017 | 31.14M |
| March 31, 2017 | 22.19M |
| December 31, 2016 | 16.61M |
| September 30, 2016 | 9.611M |
| June 30, 2016 | 9.506M |
| March 31, 2016 | 8.276M |
| December 31, 2015 | 8.313M |
| September 30, 2015 | 9.912M |
| June 30, 2015 | 10.50M |
| March 31, 2015 | 10.79M |
| December 31, 2014 | 9.722M |
| September 30, 2014 | 10.31M |
| June 30, 2014 | 10.38M |
| March 31, 2014 | 3.188M |
| December 31, 2013 | 4.203M |
| September 30, 2013 | 3.343M |
| June 30, 2013 | 6.644M |
| March 31, 2013 | 2.521M |
| December 31, 2012 | 24.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
194.50M
Minimum
Dec 2019
696.54M
Maximum
Jun 2024
519.48M
Average
584.77M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 44.92M |
| Nektar Therapeutics | 263.65M |
| Alaunos Therapeutics Inc | 0.907M |
| Oragenics Inc | 1.383M |
| Cocrystal Pharma Inc | 4.183M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 352.32M |
| Shareholders Equity (Quarterly) | -344.22M |
| Debt to Equity Ratio | -0.7625 |
| Current Ratio | 1.968 |
| Net Debt Paydown Yield | -0.10% |